Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma is a research paper published in Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 32 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: UM1CA228823, R35CA220500
National Institutes of Health
Grant: 1R35CA220500-01
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
National Institutes of Health
Grant: 2UM1CA228823-06
Children's Oncology Group Pediatric EarlyPhase Clinical Trial Network
NCI NIH HHS
Grant: R35 CA220500
NCI NIH HHS
Grant: UM1 CA228823
Fields of Study
MeSH Terms
Keywords